Asset Advisors Corp’s Bristol-Myers Squibb BMY Stock Holding History

Asset Advisors Corp’s Portfolio BMY Stock Details BMY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q2	$201K	Sell	3,627 -329	-8%	-$17.8K	0.04%	99
2018 Q1	$250K	Sell	3,956 -800	-17%	-$51.5K	0.04%	98
2017 Q4	$291K	Sell	4,756 -500	-10%	-$31.3K	0.05%	98
2017 Q3	$335K	Hold	5,256	–	–	0.06%	92
2017 Q2	$293K	Sell	5,256 -400	-7%	-$21.8K	0.05%	96
2017 Q1	$308K	Sell	5,656 -1,452	-20%	-$79.6K	0.06%	89
2016 Q4	$415K	Sell	7,108 -400	-5%	-$21.9K	0.08%	83
2016 Q3	$405K	Buy	7,508 +623	+9%	+$40K	0.08%	84
2016 Q2	$506K	Hold	6,885	–	–	0.11%	82
2016 Q1	$440K	Hold	6,885	–	–	0.1%	83
2015 Q4	$474K	Buy	6,885 +150	+2%	+$9.91K	0.11%	82
2015 Q3	$399K	Buy	6,735 +99	+1%	+$6.28K	0.1%	79
2015 Q2	$442K	Hold	6,636	–	–	0.1%	82
2015 Q1	$428K	Hold	6,636	–	–	0.1%	81
2014 Q4	$392K	Hold	6,636	–	–	0.09%	84
2014 Q3	$340K	Buy	6,636 +806	+14%	+$40.3K	0.08%	85
2014 Q2	$283K	Sell	5,830 -6,100	-51%	-$301K	0.06%	91
2014 Q1	$620K	Hold	11,930	–	–	0.15%	77
2013 Q4	$634K	Sell	11,930 -200	-2%	-$10.2K	0.15%	75
2013 Q3	$561K	Hold	12,130	–	–	0.16%	76
2013 Q2	$542K	Buy	+12,130	New	+$527K	0.16%	75

Other funds holding BMY

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Asset Advisors Corp's BMY Position: Q2 2018 in Review

Asset Advisors Corp reduced its Bristol-Myers Squibb (BMY) stake by 8.3% in Q2 2018, selling an estimated $17.8K and leaving 3,627 shares worth $201K. The position accounts for 0.04% of the portfolio, ranked #99.

Asset Advisors Corp first reported a position in BMY in Q2 2013 and has held it in 21 quarters since. The position peaked at $634K in Q4 2013. 1,691 funds tracked by Wall St. Rank hold BMY as of Q2 2018.

Asset Advisors Corp held 3,627 shares of Bristol-Myers Squibb worth $201K as of Q2 2018.
Asset Advisors Corp sold 329 Bristol-Myers Squibb shares in Q2 2018, an estimated $17.8K.
Bristol-Myers Squibb made up 0.04% of Asset Advisors Corp's portfolio in Q2 2018, its #99 holding.
Asset Advisors Corp first reported a position in Bristol-Myers Squibb in Q2 2013 and has held it in 21 quarters since.
Asset Advisors Corp's Bristol-Myers Squibb position peaked at $634K in Q4 2013.
1,691 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2018.

Based on Asset Advisors Corp's 13F filing for Q2 2018, filed 20 Jul 2018.